Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gain Therapeutics (GANX) Tax Rate (2020 - 2025)

Historic Tax Rate for Gain Therapeutics (GANX) over the last 6 years, with Q3 2025 value amounting to 11.6%.

  • Gain Therapeutics' Tax Rate fell 113500.0% to 11.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.29%, marking a year-over-year decrease of 60700.0%. This contributed to the annual value of 2.4% for FY2024, which is 20400.0% down from last year.
  • According to the latest figures from Q3 2025, Gain Therapeutics' Tax Rate is 11.6%, which was down 113500.0% from 2.49% recorded in Q2 2025.
  • Over the past 5 years, Gain Therapeutics' Tax Rate peaked at 0.26% during Q4 2021, and registered a low of 11.6% during Q3 2025.
  • Its 5-year average for Tax Rate is 1.55%, with a median of 0.29% in 2023.
  • Per our database at Business Quant, Gain Therapeutics' Tax Rate skyrocketed by 14100bps in 2023 and then tumbled by -113500bps in 2025.
  • Gain Therapeutics' Tax Rate (Quarter) stood at 0.26% in 2021, then plummeted by -765bps to 1.7% in 2022, then skyrocketed by 83bps to 0.29% in 2023, then crashed by -2911bps to 8.74% in 2024, then tumbled by -33bps to 11.6% in 2025.
  • Its Tax Rate stands at 11.6% for Q3 2025, versus 2.49% for Q2 2025 and 2.27% for Q1 2025.